2018
DOI: 10.1530/joe-18-0286
|View full text |Cite
|
Sign up to set email alerts
|

cGMP-dependent protein kinase-2 regulates bone mass and prevents diabetic bone loss

Abstract: NO/cGMP signaling is important for bone remodeling in response to mechanical and hormonal stimuli, but the downstream mediator(s) regulating skeletal homeostasis are incompletely defined. We generated transgenic mice expressing a partly-activated, mutant cGMP-dependent protein kinase type 2 (PKG2) under control of the osteoblast-specific Col1a1 promoter to characterize the role of PKG2 in post-natal bone formation. Primary osteoblasts from these mice showed a two- to three-fold increase in basal and total PKG2… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
21
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 18 publications
(34 citation statements)
references
References 59 publications
(120 reference statements)
2
21
0
Order By: Relevance
“…PKG1-deficient and control osteoblasts proliferated similarly when stimulated with the membrane-permeable cGMP analog 8-CPT-cGMP or with 20% fetal bovine serum, measured after a period of growth factor deprivation in medium containing 0.1% FBS ( Figure 3C). These data are consistent with PKG2, rather than PKG1, mediating proliferative responses of osteoblasts to various growth stimuli, including cGMP (18,21,26).…”
Section: a And B)supporting
confidence: 81%
See 3 more Smart Citations
“…PKG1-deficient and control osteoblasts proliferated similarly when stimulated with the membrane-permeable cGMP analog 8-CPT-cGMP or with 20% fetal bovine serum, measured after a period of growth factor deprivation in medium containing 0.1% FBS ( Figure 3C). These data are consistent with PKG2, rather than PKG1, mediating proliferative responses of osteoblasts to various growth stimuli, including cGMP (18,21,26).…”
Section: a And B)supporting
confidence: 81%
“…We crossed mice carrying Prkg1 alleles flanked by loxP sites (Prkg1 fl/fl ) with mice expressing Cre recombinase under control of the 2.3-kb collagen1a1 promoter (Col1a1-CRE Tg/+ ) -both in a C57BL/6 background -to generate mice with osteoblast-specific Prkg1 knockout (genotype Col1a1-CRE Tg/+ Prkg1 fl/fl ), as described in Supplemental Figure 1, A and B; supplemental material available online with this article; https://doi.org/10.1172/jci.insight.135355DS1. We and others have shown that the 2.3-kb Col1a1 promoter is specifically expressed in cells of osteoblastic lineage, from committed osteoblast precursors to mature osteocytes (21,22). Prkg1 mRNA in tibial bone shafts was reduced by more than 80% in transgene-positive Prkg1 OB-KO mice compared with control, transgene-negative Prkg1 fl/fl littermates, while Prkg2 mRNA was not significantly reduced ( Figure 1A).…”
Section: Resultsmentioning
confidence: 77%
See 2 more Smart Citations
“…Primary osteoblasts from Prkg2 –/– mice showed decreased c‐fos (Fos) and Fra 2 ( Fosl2 ) expression, which are involved in osteoblast cell cycle regulation 34 . On the other hand, osteoblast‐specific PKG2 gain‐of‐function mutation (Col1a1‐ Prkg2 RQ ) showed significantly increased bone formation parameters, such as trabecular mineralizing surface, MAR, and BFR compared with littermates 37 . Interestingly, this skeletal phenotype was more evident in male mice, suggesting the possible interaction of sex hormones and the NO–cGMP–PKG2 signal.…”
Section: No–cgmp–pkg Signaling and Bonementioning
confidence: 99%